Episode
PAYX Stock: Paychex Beat And Grew 12% - So Why Did It Fall? Q4 FY2026
- Published
- Jun 24, 2026
- Duration seconds
- 663
- Processing state
not_requested
Actions
POST https://stenobird.com/v1/public/podcasts/charged-alpha-stock-encyclopedia-7819792/episodes/payx-stock-paychex-beat-and-grew-12-so-why-did-it-fall-q4-fy2026/transcription-requests
Idempotently request low-priority transcript generation for this episode.GET https://stenobird.com/podcast/charged-alpha-stock-encyclopedia-7819792/payx-stock-paychex-beat-and-grew-12-so-why-did-it-fall-q4-fy2026.md
Read the agent-friendly Markdown representation of this episode resource.
Summary
PAYX (Paychex) reported Q4 FY2026 earnings on 2026-06-24. Stock fell 3.6% on the print. Here's the breakdown: Is PAYX a buy, hold, or sell after this quarter? In this Paychex (PAYX) Q4 FY2026 earnings breakdown we cover the revenue and EPS print, the 8-quarter trend, segment detail, the free-cash-flow bridge, forward guidance, peer valuation, and management & earnings quality - ending with a clear price-aware Buy / Hold / Avoid Call and a Wall Street consensus comparison. If you follow Industrials stocks or PAYX earnings, this is the Q4 FY2026 deep dive. 🎧 Listen on Podbean: https://chargedalpha.podbean.com (also on Apple Podcasts & Spotify) 🔔 Subscribe for daily earnings deep-dives → @ChargedAlpha | Call tracker: chargedalpha.com THE CALL: HOLD (3/5 conviction, MODERATE) - CURRENT @ $94.45 - HOLD - BUY below $85.00 with $78.00 stop - AVOID above $115.00 TRIGGER: Organic revenue growth re-accelerates above ~6% (WISE AI cross-sell + PEO attach working) for two quarters WINDOW: Through Q1 FY27 earnings (September 2026) TRACKER: chargedalpha.com WALL STREET CONSENSUS - Ratings: 0 Strong Buy / 1 Buy / 15 Hold / 3 Sell / 0 Strong Sell - HOLD - Median 12-month price target: $106.00 (range $90 - $134) - Charged Alpha vs consensus: IN-LINE THESIS The fortress SMB payroll/HR compounder - recurring revenue, ~44% margins, $2.2B annual capital return - that just digested the $4.1B Paycor deal, but whose FY27 guide reveals ~5% organic growth now that the acquisition laps. Bull lever: If WISE agentic-AI cross-sell and PEO attach re-accelerate organic growth toward high-single-digits while margins expand to ~44%, the cheap ~16x multiple re-rates and the dividend keeps compounding. Key risk: If organic growth stays stuck near 5% amid soft SMB hiring and float income fades with…